• ACADIA Pharmaceuticals (NASDAQ:ACAD) Receives Overweight Rating from Cantor Fitzgerald

    来源: Buzz FX / 28 2月 2025 11:01:14   America/Chicago


    ACADIA Pharmaceuticals (NASDAQ:ACAD) Receives Overweight Rating from Cantor Fitzgerald Written by MarketBeat February 28, 2025 Share Link copied to clipboard. ACADIA Pharmaceuticals ( NASDAQ:ACAD - Get Free Report ) 's stock had its "overwe
    Read more...
分享